Physician

Robert Edward Wenz, M.D.

According to 2025 Medicare claims, Robert Wenz, M.D. (NPI: 1639172984) practices ophthalmology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Lake, OH. This provider's primary affiliated billing organization is VITREO-RETINAL CONSULTANTS, INC. (NPI: 1750347662; TIN: 341390523) and primary practice location at 44060-6017.

Wenz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 482 traditional Medicare patients, billed 16,600 HCPCS/CPT codes, and received $1,056,734 in Medicare payments. The top billing code was J3590 (Unclassified biologics). Part D data shows 278 prescription claims across 119 beneficiaries totaling $6,325 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 26 records totaling $598. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $19,440 to $6,325. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$840K$1.7M2015 Medicare payment: $1,259,618 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,421,302 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,336,617 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,459,020 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,501,902 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,320,430 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,497,900 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,679,120 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,633,581 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,056,734 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159588,490$1,259,618
20161,0259,475$1,421,302
20171,0628,549$1,336,617
20189808,293$1,459,020
20199828,649$1,501,902
20208167,269$1,320,430
20218707,810$1,497,900
202295812,588$1,679,120
202380725,773$1,633,581
202448216,600$1,056,734

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$23K2015 Drug cost: $19,440 (USD; Tot_Drug_Cst)2016 Drug cost: $17,695 (USD; Tot_Drug_Cst)2017 Drug cost: $23,132 (USD; Tot_Drug_Cst)2018 Drug cost: $19,167 (USD; Tot_Drug_Cst)2019 Drug cost: $19,866 (USD; Tot_Drug_Cst)2020 Drug cost: $16,454 (USD; Tot_Drug_Cst)2021 Drug cost: $17,102 (USD; Tot_Drug_Cst)2022 Drug cost: $21,107 (USD; Tot_Drug_Cst)2023 Drug cost: $18,994 (USD; Tot_Drug_Cst)2024 Drug cost: $6,325 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015155348$19,440
2016150340$17,695
2017161390$23,132
2018181414$19,167
2019178409$19,866
2020152362$16,454
2021161338$17,102
2022224533$21,107
2023254546$18,994
2024119278$6,325

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J3590Unclassified biologics103250$120
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more8484$113
67028Injection of drug into eye228720$79
92014Established patient complete exam of visual system392834$78
92134Imaging of retina4391,002$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate632,740$3,699
Ketorolac TromethamineKetorolac Tromethamine492,525$921
Diclofenac SodiumDiclofenac Sodium441,089$531
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha31595$342
TobramycinTobramycin321,258$298

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.26$598Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Robert Edward Wenz, M.D.?

Tedicare shows public-source Medicare data for Robert Edward Wenz, M.D. (NPI 1639172984), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Edward Wenz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Edward Wenz, M.D.?

Robert Edward Wenz, M.D. is linked to VITREO-RETINAL CONSULTANTS, INC. (billing NPI 1750347662) in the available physician profile data.

Does Robert Edward Wenz, M.D. have Open Payments data?

Robert Edward Wenz, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.